Text Size A A A

History

Print Home » History

Secondary menu

1950

Established in Israel to manufacture finished pharmaceutical products

1961

Started chemical synthesis (API production) in Israel

1984

Established topical product operations in Canada

1988

Taro enters the U.S. market with its first FDA-approved topical product.

2003

Established TaroPharma branded division in U.S.

2010

Sun Pharma acquires a controlling interest In Taro

2012

Over $1 Billion Gross Sales (IMS Calendar Year Sales 2012)

2012

Taro re-listed on the NYSE providing improved access to capital markets.